CD8A and cancer: For example, some studies illustrated that TOX was positively correlated with larger tumor size, lower differentiation, advanced TNM stage and predicting exhaustion and low infiltration of tumor infiltrating CD8 + T cells in tumor microenvironment, highlighting a potential biomarker for cancer immunotherapy efficacy [10, 11, 20–22].